Gennex Lab.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE509C01026
  • NSEID:
  • BSEID: 531739
INR
7.11
-0.9 (-11.24%)
BSENSE

Mar 30

BSE+NSE Vol: 15.7 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 930938,
    "name": "Gennex Lab.",
    "stock_name": "Gennex Lab.",
    "full_name": "Gennex Laboratories Ltd",
    "name_url": "stocks-analysis/gennex-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "7.11",
    "chg": -0.9,
    "chgp": "-11.24%",
    "dir": -1,
    "prev_price": "8.01",
    "mcapval": "195.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531739,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE509C01026",
    "curr_date": "Mar 30",
    "curr_time": "",
    "bse_nse_vol": "15.7 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 30, 2026",
    "traded_date_str": "2026 03 30",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gennex-lab-930938-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Five Consecutive Losses Push Gennex Laboratories Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-stock-hits-52-week-low-amid-continued-downtrend-3925272",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_priceRelatedfactors_3925272.png",
        "date": "2026-03-30 14:21:21",
        "description": ""
      },
      {
        "title": "Five Consecutive Losses Push Gennex Laboratories Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-stock-hits-52-week-low-amid-market-downturn-3920358",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_priceRelatedfactors_3920358.png",
        "date": "2026-03-27 15:57:46",
        "description": ""
      },
      {
        "title": "Markets Rally, But Gennex Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-stock-falls-to-52-week-low-of-rs806-3916038",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_priceRelatedfactors_3916038.png",
        "date": "2026-03-25 10:48:35",
        "description": "Despite a broad market upswing, Gennex Laboratories Ltd has slipped to a fresh 52-week low of Rs 8.06 on 25 Mar 2026, marking a near 53% decline from its 52-week high of Rs 17.25. This divergence from the market rally highlights persistent headwinds for the micro-cap pharmaceutical player."
      },
      {
        "title": "Gennex Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-is-rated-sell-3909891",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_mojoScore_3909891.png",
        "date": "2026-03-24 10:10:02",
        "description": "Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Markets Rally, But Gennex Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-stock-hits-52-week-low-at-rs83-amid-sector-and-market-downturn-3907844",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_priceRelatedfactors_3907844.png",
        "date": "2026-03-23 12:36:11",
        "description": ""
      },
      {
        "title": "Gennex Laboratories Declines 3.09%: Valuation Shifts and Market Pressures Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-declines-309-valuation-shifts-and-market-pressures-shape-the-week-3905310",
        "imagepath": "",
        "date": "2026-03-21 15:01:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Mar:</strong> New 52-week low at Rs.9.3</p>\n                    <p><strong>19 Mar:</strong> Valuation parameters upgraded to very attractive</p>\n                    <p><strong>20 Mar:</strong> Week closes at Rs.9.40 (-3.09%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.9.70</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.9.40</div><div class=\"stat-change negative\">-3.09%</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Low</div><div class=\"s..."
      },
      {
        "title": "Gennex Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-3899552",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_valuationdot_3899552.png",
        "date": "2026-03-19 08:00:35",
        "description": "Gennex Laboratories Ltd has seen a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, despite a challenging recent performance relative to the broader market. This change is underpinned by improved price-to-earnings and price-to-book value ratios, positioning the micro-cap pharmaceutical player as a compelling consideration within its sector."
      },
      {
        "title": "Gennex Laboratories Ltd Stock Hits 52-Week Low at Rs.9.3",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-stock-hits-52-week-low-at-rs93-3893725",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_priceRelatedfactors_3893725.png",
        "date": "2026-03-16 11:32:38",
        "description": "Gennex Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a fresh 52-week low of Rs.9.3 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its valuation and performance metrics."
      },
      {
        "title": "Gennex Laboratories Ltd Stock Falls to 52-Week Low of Rs.9.61",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-stock-falls-to-52-week-low-of-rs961-3890247",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_priceRelatedfactors_3890247.png",
        "date": "2026-03-13 19:59:59",
        "description": "Gennex Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.9.61 today, marking a significant decline amid broader market weakness and sectoral underperformance."
      }
    ],
    "total": 159,
    "sid": "930938",
    "stock_news_url": "https://www.marketsmojo.com/news/gennex-laboratories-930938"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2026",
      "details": "Notice is hereby given that in pursuance of SEBI (PIT) Regulations 2015 and Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Insiders the Trading Window for dealing in the Securities of the Company shall remain closed from April 01 2026 till 48 hours after the public announcement through Board of Directors in their meeting held for announcing the audited Financial Results for the Quarter and year ended on March 31 2026 along with other matters for which Trading window is required to be closed. The Board Meeting Date to approve the audited financial results of the Company for the Quarter and year ended on March 31 2026 will be informed in due course. All Promoters/designated/connected persons are advised not to trade in the securities of the Company directly or indirectly during the aforesaid period of Closure of Trading Window. We request you to take the above information on record and acknowledge receipt of the same.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "17-Feb-2026",
      "details": "Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper Publication on Unaudited (Standalone & Consolidated) Financial Results for the Quarter and Nine months ended December 31 2025 announced by the Board of Directors in its meeting held on Saturday February 14 2026. Financial Results had been published in both Business Standard (English) and Saksham ( Telugu-Local) on Monday February 16 2026. We request you to take the above information on record and acknowledge receipt of the same.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "14-Feb-2026",
      "details": "Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations 2015 we would like to inform you that based on recommendation of Nomination and Remuneration Committee the Board of Directors approved the appointment of Ms. Khushboo Kachhawa (DIN#10872432) as an Additional (Non-Executive & Independent) Women Director of the Company with effect from February 14 2026 subject to approval of the shareholders of the Company. Ms Khushbu Kachhawa will be a Non-Executive & Independent Women Director and she is not related to Promoter or Promoter Group and fulfills the criteria as required under the provisions of the Companies Act 2013 and rules framed thereunder and Listing Regulations. The relevant details and disclosure under Form B enclosed herewith. We request you to take the above information on record and acknowledge the receipt of the same.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Gennex Laboratories Ltd has announced <strong>1:10</strong> stock split, ex-date: 14 Dec 09",
          "dt": "2009-12-14",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Gennex Laboratories Ltd has announced <strong>1:2</strong> rights issue, ex-date: 21 Jul 22",
          "dt": "2022-07-21",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views

Gennex Laboratories Declines 3.09%: Valuation Shifts and Market Pressures Shape the Week

2026-03-21 15:01:09
stock-recommendationAnnouncement

Closure of Trading Window

25-Mar-2026 | Source : BSE

Notice is hereby given that in pursuance of SEBI (PIT) Regulations 2015 and Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Insiders the Trading Window for dealing in the Securities of the Company shall remain closed from April 01 2026 till 48 hours after the public announcement through Board of Directors in their meeting held for announcing the audited Financial Results for the Quarter and year ended on March 31 2026 along with other matters for which Trading window is required to be closed. The Board Meeting Date to approve the audited financial results of the Company for the Quarter and year ended on March 31 2026 will be informed in due course. All Promoters/designated/connected persons are advised not to trade in the securities of the Company directly or indirectly during the aforesaid period of Closure of Trading Window. We request you to take the above information on record and acknowledge receipt of the same.

Announcement under Regulation 30 (LODR)-Newspaper Publication

17-Feb-2026 | Source : BSE

Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper Publication on Unaudited (Standalone & Consolidated) Financial Results for the Quarter and Nine months ended December 31 2025 announced by the Board of Directors in its meeting held on Saturday February 14 2026. Financial Results had been published in both Business Standard (English) and Saksham ( Telugu-Local) on Monday February 16 2026. We request you to take the above information on record and acknowledge receipt of the same.

Announcement under Regulation 30 (LODR)-Change in Management

14-Feb-2026 | Source : BSE

Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations 2015 we would like to inform you that based on recommendation of Nomination and Remuneration Committee the Board of Directors approved the appointment of Ms. Khushboo Kachhawa (DIN#10872432) as an Additional (Non-Executive & Independent) Women Director of the Company with effect from February 14 2026 subject to approval of the shareholders of the Company. Ms Khushbu Kachhawa will be a Non-Executive & Independent Women Director and she is not related to Promoter or Promoter Group and fulfills the criteria as required under the provisions of the Companies Act 2013 and rules framed thereunder and Listing Regulations. The relevant details and disclosure under Form B enclosed herewith. We request you to take the above information on record and acknowledge the receipt of the same.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Gennex Laboratories Ltd has announced 1:10 stock split, ex-date: 14 Dec 09

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Gennex Laboratories Ltd has announced 1:2 rights issue, ex-date: 21 Jul 22